We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Image: ‘Virtual biopsy’ allows clinicians to analyze skin noninvasively (Photo courtesy of Stanford Medicine)

Virtual Skin Biopsy Determines Presence of Cancerous Cells

A "virtual biopsy" could allow surgeons to determine if they have completely removed the tumor during the procedure itself by using real-time imaging instead of waiting for traditional pathology results. More...
12 Apr 2024
Image: The groundbreaking treatment approach has shown promise in hard-to-treat cancers (Photo courtesy of 123RF)

Genetic Testing Combined With Personalized Drug Screening On Tumor Samples to Revolutionize Cancer Treatment

For the first time, researchers have combined genetic testing with personalized drug screening directly on tumor samples to identify the right treatment for children with relapsed cancers. More...
12 Apr 2024
Image: ESCMID has modernized its branding and communications (Photo courtesy of ESCMID)

ECCMID Congress Name Changes to ESCMID Global

ESCMID has decided to bring all of its various sub-brands more closely together under one large ESCMID umbrella, including changing the name of its congress to “ESCMID Global”. More...
11 Apr 2024
Image: AI analysis of DNA fragmentomes and protein biomarkers noninvasively detects ovarian cancer (Photo courtesy of Adobe Stock)

Blood-Based Machine Learning Assay Noninvasively Detects Ovarian Cancer

A new study has demonstrated that a blood-based machine learning assay can effectively distinguish patients with ovarian cancer from healthy controls or patients with benign ovarian masses. More...
11 Apr 2024
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Researchers have taken a big step towards building inexpensive hardware that could make mass spectrometry local by using 3D printing to create a low-cost ionizer. More...
10 Apr 2024
Image: Both companies will invest EURO 150 million in research, development, and distribution of the Vivalytic analysis platform (Photo courtesy of Bosch)

Bosch and Randox Partner to Make Strategic Investment in Vivalytic Analysis Platform

Bosch has entered into a strategic partnership with Randox that will lead to an investment of about EURO 150 million in joint research, development, and sales activities for new tests for the Vivalytic analysis platform. More...
10 Apr 2024
Image: The PATHFAST hs-cTnI-II high-sensitivity troponin assay has been developed for the PATHFAST Biomarker Analyzer (Photo courtesy of Polymedco)

POC Myocardial Infarction Test Delivers Results in 17 Minutes

A high-sensitivity cardiac troponin I (hs-cTnI-II) test approved for point-of-care (POC) use in the United States allows EDs and other acute care settings to achieve quicker and more precise diagnostic and treatment decisions than previously possible. More...
10 Apr 2024
Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Real-time PCR System
GentierX3 Series